A war on “prediabetes” has created millions of new patients and a tempting opportunity for pharma. But how real is the condition, and is it good medicine?
“Practitioners should be careful about the potential implications of any active intervention for people ‘diagnosed’ with intermediate hyperglycaemia (‘prediabetes’)” cochrane.
- Read Dubious diagnosis and The war on ‘prediabetes’ could be a boon for pharma—but is it good medicine?
- Video published on 7 Mar 2019, by ScienceMag.